Zhongxing X. Jiang
#1 Jianshe East Road
Zhengzhou, 450000, China
Zhengzhou, 450000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Reply to 'Immortal time bias limits the conclusion that post-transplant hypomethylating agent maintenance improves outcomes in myelodysplastic syndromes'.
Journal: British journal of haematology
Published: June 18, 2026
Risk factor analysis and prediction model construction for delayed erythroid hematopoietic reconstitution after allogeneic hematopoietic stem cell transplantation: a single-center retrospective study.
Journal: Frontiers in oncology
Published: April 22, 2026
Contrasting impacts of pretransplant cytoreduction and post-transplant maintenance on outcomes of allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes: Real-world multicentre evidence.
Journal: British journal of haematology
Published: January 26, 2026
Editorial: Antibody-based novel target immunotherapy in hematological malignancy.
Journal: Frontiers in oncology
Published: October 18, 2025
Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.
Journal: European journal of haematology
Published: October 10, 2025
Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trial.
Journal: Research and practice in thrombosis and haemostasis
Published: July 03, 2025
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study.
Journal: The Lancet. Haematology
Published: May 15, 2025
IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming.
Journal: eLife
Published: April 29, 2025
Single-cell RNA sequencing uncovers m6A regulator-defined T-cell subpopulations and YTHDF1-HSP90AB1-MYC therapeutic axis in T-cell acute lymphoblastic leukemia.
Journal: Chinese medical journal
Published: April 21, 2025
Recent development in bispecific antibody immunotherapy for hematological malignancies.
Journal: Critical reviews in oncology/hematology
Published: March 27, 2025
Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024.
Journal: Frontiers in oncology
Published: January 24, 2025
Mechanisms of resistance to CAR-T cell therapy in multiple myeloma: latest updates from the 2024 ASH annual meeting.
Journal: Experimental hematology & oncology
Published: December 19, 2024
Last Updated: 09/26/2026